MedTrace Logo

Xanthine Oxidase and Uric Acid Origin in Preeclamptic Women

NCT04463940 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2022-07-25

No results posted yet for this study

Summary

Findings regarding the presence of xanthine oxidase and uric acid in different blood locations is important in preeclamptic women. We aim to detecting Xanthine oxidase and uric acid levels in both umbilical cord artery and vein as well as maternal blood (3 "locations") in pregnant women with and without diagnosis of preeclampsia. The study population will be divided into groups matching the three "locations" in order to describe and compare outcome levels.

Conditions

  • Pre-Eclampsia
  • Hyperuricemia

Interventions

OTHER

No intervention

No intervention

Sponsors & Collaborators

  • Barzilai Medical Center

    lead OTHER

Principal Investigators

  • Simon Shenhav, Dr · Barzilai University Medical Center

Eligibility

Min Age
20 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-30
Primary Completion
2023-08-31
Completion
2024-08-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04463940 on ClinicalTrials.gov